Literature DB >> 32224541

The Immunomodulatory Effects and Mechanisms of Tim-3 Action in the Early Stage of Mice with Severe Acute Pancreatitis.

Min Lin1, Jin Huang, Wei-Chang Chen, Zhi-Ning Fan, Xihu Qin.   

Abstract

BACKGROUND: Tim-3 has been considered as an ideal target for the immunotherapy of inflammation, but it is unclear whether Tim-3 also plays an important role in acute pancreatitis (AP), as well.
OBJECTIVE: To identify the immunomodulatory effects and mechanisms of Tim-3 action in the early stages of severe acute pancreatitis in mice.
METHODS: Male BALB/c mice were randomly divided into sham injection group, severe acute pancreatitis group, and anti-Tim-3 treated group. Histopathological scores of the pancreas were calculated, pancreatic myeloperoxidase (MPO) activity was assessed. The concentrations of serum IL-6, IL-10, and TNF-α were evaluated by ELISA method. Quantitative RT-PCR was performed to detect the transcripts of Tim-3, IL-6, IL-10, TNF-α, and TLR4 in peritoneal macrophages. The levels of peritoneal macrophages Tim-3, TLR4, MyD88, and NF-kB p65 were measured by western blot analysis.
RESULTS: The pathological scores of the anti-Tim-3 treated group (11.5 ± 1.3) significantly increased compared with the sham (1.3 ± 0.5) and SAP groups (6.9 ± 1.0). Furthermore, the downregulation of Tim-3 significantly aggravated mouse pancreatic tissue damage. It was further shown that Tim-3 negatively regulated the production of pro-inflammatory cytokines, IL-6 and TNF-α, as well as anti-inflammatory cytokine IL-10. Of note, the negative regulation of inflammatory cytokines by Tim-3 was mediated by the activation of TLR4/MyD88 NF-kB signaling pathway.
CONCLUSION: Our study showed that Tim-3 might play an important role in the development of AP through regulating the inflammatory response.

Entities:  

Year:  2020        PMID: 32224541     DOI: 10.22034/iji.2020.80294

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  2 in total

1.  Clinical value of the sTim‑3 level in chronic kidney disease.

Authors:  Lingli Chen; Yuan Qin; Bo Lin; Xiaomei Yu; Shaoxiong Zheng; Xiumei Zhou; Xiaobin Liu; Yigang Wang; Biao Huang; Juan Jin; Liang Wang
Journal:  Exp Ther Med       Date:  2022-07-29       Impact factor: 2.751

2.  Silencing of CREB Inhibits HDAC2/TLR4/NF-κB Cascade to Relieve Severe Acute Pancreatitis-Induced Myocardial Injury.

Authors:  Longfei Pan; Zequn Niu; Yanxia Gao; Liming Wang; Zhong Liu; Jie Liu; Jiangli Sun; Honghong Pei
Journal:  Inflammation       Date:  2021-03-16       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.